HIGHLIGHTS
- who: Alexey S. Vasilchenko from the University of Wisconsin-Madison, United States have published the research work: Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A, in the Journal: (JOURNAL)
- what: The aim of this work is to evaluate the dynamics of the resistance development of S. aureus FDA209P to gausemycin A in comparison with ramoplanin and daptomycin, which are similar in structure and mechanism of action, respectively. The study showed that adding gausemycin A into the reaction medium with S. aureus FDA209P quenched SYTO9 fluorescence in a dose-dependent manner . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.